43.72
4.74%
1.98
プレマーケット:
43.89
0.17
+0.39%
前日終値:
$41.74
開ける:
$42.14
24時間の取引高:
850.24K
Relative Volume:
0.95
時価総額:
$2.94B
収益:
$2.82B
当期純損益:
$-1.87B
株価収益率:
-1.567
EPS:
-27.9
ネットキャッシュフロー:
$-96.80M
1週間 パフォーマンス:
+6.37%
1か月 パフォーマンス:
-2.50%
6か月 パフォーマンス:
+26.03%
1年 パフォーマンス:
-38.72%
Quidelortho Corporation Stock (QDEL) Company Profile
名前
Quidelortho Corporation
セクター
電話
(858) 552-1100
住所
9975 SUMMERS RIDGE ROAD, SAN DIEGO, CA
QDEL を他の銘柄と比較する
株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
---|---|---|---|---|---|---|
QDEL
Quidelortho Corporation
|
43.72 | 2.94B | 2.82B | -1.87B | -96.80M | -27.90 |
ABT
Abbott Laboratories
|
116.79 | 201.01B | 41.22B | 5.77B | 6.49B | 3.29 |
SYK
Stryker Corp
|
395.85 | 150.90B | 21.97B | 3.59B | 3.21B | 9.33 |
BSX
Boston Scientific Corp
|
100.91 | 148.72B | 15.91B | 1.79B | 1.89B | 1.21 |
MDT
Medtronic Plc
|
88.38 | 113.33B | 33.00B | 4.29B | 5.50B | 3.27 |
EW
Edwards Lifesciences Corp
|
69.97 | 41.27B | 6.60B | 4.16B | 490.10M | 6.93 |
Quidelortho Corporation Stock (QDEL) Upgrades & Downgrades
日付 | アクション | アナリスト | 評価の変更 |
---|---|---|---|
2024-12-11 | アップグレード | Citigroup | Neutral → Buy |
2024-12-10 | 開始されました | Jefferies | Hold |
2024-09-19 | 再開されました | UBS | Neutral |
2024-09-05 | アップグレード | Craig Hallum | Hold → Buy |
2024-03-04 | ダウングレード | UBS | Neutral → Sell |
2024-02-14 | ダウングレード | JP Morgan | Neutral → Underweight |
2023-12-11 | ダウングレード | Citigroup | Buy → Neutral |
2022-12-12 | アップグレード | Citigroup | Neutral → Buy |
2022-12-07 | 開始されました | RBC Capital Mkts | Outperform |
2022-10-14 | アップグレード | UBS | Sell → Neutral |
2022-09-19 | 開始されました | Citigroup | Neutral |
2022-07-20 | 開始されました | UBS | Sell |
2022-06-17 | 再開されました | JP Morgan | Neutral |
2022-02-22 | アップグレード | Raymond James | Outperform → Strong Buy |
2021-01-22 | アップグレード | Raymond James | Mkt Perform → Outperform |
2020-05-12 | ダウングレード | JP Morgan | Neutral → Underweight |
2020-03-26 | ダウングレード | Barclays | Overweight → Equal Weight |
2018-10-23 | 再開されました | Raymond James | Strong Buy |
2018-03-08 | アップグレード | Raymond James | Outperform → Strong Buy |
2018-01-22 | 繰り返されました | Barclays | Overweight |
2018-01-04 | アップグレード | CL King | Neutral → Buy |
2017-09-19 | アップグレード | Piper Jaffray | Neutral → Overweight |
2017-07-18 | アップグレード | Canaccord Genuity | Hold → Buy |
2017-07-18 | アップグレード | William Blair | Mkt Perform → Outperform |
2017-04-25 | 繰り返されました | Canaccord Genuity | Hold |
2017-02-17 | 開始されました | CL King | Neutral |
2016-12-16 | ダウングレード | Piper Jaffray | Overweight → Neutral |
2016-06-13 | アップグレード | Raymond James | Mkt Perform → Outperform |
2016-02-18 | 繰り返されました | Barclays | Overweight |
2016-02-09 | ダウングレード | Canaccord Genuity | Buy → Hold |
2016-01-08 | 繰り返されました | Canaccord Genuity | Buy |
2015-12-14 | ダウングレード | Raymond James | Outperform → Mkt Perform |
2015-09-02 | 開始されました | Barclays | Overweight |
2013-07-31 | 繰り返されました | Canaccord Genuity | Buy |
2011-03-03 | ダウングレード | Wedbush | Outperform → Neutral |
すべてを表示
Quidelortho Corporation (QDEL) 最新ニュース
QuidelOrtho Stock Down Despite Solid Preliminary Q4 Revenues - MSN
QuidelOrtho (NASDAQ:QDEL shareholders incur further losses as stock declines 6.4% this week, taking three-year losses to 59% - Simply Wall St
QuidelOrtho may be takeover, activist target with CEO exit, share slumpanalyst - MSN
Oak Thistle LLC Acquires New Stake in QuidelOrtho Co. (NASDAQ:QDEL) - MarketBeat
QuidelOrtho lets go off CEO Douglas Bryant - MSN
QuidelOrtho Breaks Below 200-Day Moving AverageNotable for QDEL - Nasdaq
QuidelOrtho (NASDAQ:QDEL) Stock Price Down 3.2%Here's Why - MarketBeat
Why QuidelOrtho Shares Are Struggling Despite Optimism - TipRanks
Moody National Bank Trust Division Grows Position in QuidelOrtho Co. (NASDAQ:QDEL) - MarketBeat
QuidelOrtho reports Q4 revenue in line with guidance By Investing.com - Investing.com Australia
QuidelOrtho Corp (QDEL) Trading Down 4.21% on Jan 13 - GuruFocus.com
QuidelOrtho sees Q4 revenue $702M -$707M, consensus $698.04M - TipRanks
QuidelOrtho announces preliminary Q4 2024 revenue in range of $702 million to $707 million - MSN
QuidelOrtho reports Q4 revenue in line with guidance - Investing.com
QuidelOrtho Announces Preliminary Unaudited Revenue for Fourth Quarter 2024 - The Bakersfield Californian
Barclays PLC Sells 41,945 Shares of QuidelOrtho Co. (NASDAQ:QDEL) - MarketBeat
Stocks Showing Improved Relative Strength: QuidelOrtho - Inkl
Quidel completes Ortho deal, emerges as QuidelOrtho - LabPulse
Kuehn Law Encourages Investors of QuidelOrtho Corporation to Contact Law Firm - PR Newswire
JPMorgan Chase & Co. Has $56.25 Million Stock Holdings in QuidelOrtho Co. (NASDAQ:QDEL) - MarketBeat
Immunoassay Market Strategies, Trends. Forecasts Report 2025: The Drive Towards Newer, More Efficient Diagnostic Instruments - GlobeNewswire Inc.
QuidelOrtho to Present at the 43rd Annual J.P. Morgan Healthcare Conference - BioSpace
QuidelOrtho Co. (NASDAQ:QDEL) Given Average Recommendation of "Hold" by Brokerages - MarketBeat
QuidelOrtho Co. (NASDAQ:QDEL) Stock Position Increased by Principal Financial Group Inc. - MarketBeat
QuidelOrtho files to sell 8.26M shares of common stocks by selling shareholders - MSN
QuidelOrtho Co. (NASDAQ:QDEL) Shares Sold by Barclays PLC - MarketBeat
Geode Capital Management LLC Buys 16,059 Shares of QuidelOrtho Co. (NASDAQ:QDEL) - MarketBeat
Does QuidelOrtho Corporation (QDEL) Have Healthy Long-Term Growth Prospects? - MSN
Insider Buying: QuidelOrtho President Bought US$250k Of Shares - Yahoo Finance
QuidelOrtho's SWOT analysis: stock upgrade amid cost cuts, product launch By Investing.com - Investing.com Australia
State Street Corp Boosts Holdings in QuidelOrtho Co. (NASDAQ:QDEL) - MarketBeat
QuidelOrtho's SWOT analysis: stock upgrade amid cost cuts, product launch - Investing.com
Quantinno Capital Management LP Trims Stock Position in QuidelOrtho Co. (NASDAQ:QDEL) - MarketBeat
QuidelOrtho Co. (NASDAQ:QDEL) Shares Sold by The Manufacturers Life Insurance Company - MarketBeat
Brian J. Blaser Buys 6,033 Shares of QuidelOrtho Co. (NASDAQ:QDEL) Stock - MarketBeat
QuidelOrtho Announces Appointment of Two Independent Directors to its Board - Milton Daily Standard
Citigroup Upgrades QuidelOrtho (QDEL) - MSN
Citi upgrades Quidel stock to Buy on FY25 growth prospects and margin improvement efforts - Investing.com
QuidelOrtho (NASDAQ:QDEL) Upgraded at Citigroup - MarketBeat
QuidelOrtho expands board with healthcare veterans By Investing.com - Investing.com Canada
QuidelOrtho upgraded to Buy from Neutral at Citi - TipRanks
MetLife Investment Management LLC Sells 25,230 Shares of QuidelOrtho Co. (NASDAQ:QDEL) - MarketBeat
Jefferies Initiates Coverage of QuidelOrtho (QDEL) with Hold Recommendation - MSN
QuidelOrtho's SWOT analysis: stock outlook amid strategic shifts, market challenges - Investing.com Nigeria
QuidelOrtho (NASDAQ:QDEL) Coverage Initiated at Jefferies Financial Group - MarketBeat
QuidelOrtho expands board with healthcare veterans - Investing.com India
QuidelOrtho Strengthens Board with Experienced Healthcare CEOs - TipRanks
Quidelortho Corporation (QDEL) 財務データ
収益
当期純利益
現金流量
EPS
Quidelortho Corporation (QDEL) インサイダートレーディング
インサイダートレーディング | 関係 | 日付 | 取引 | コスト | #株式 | 値 ($) | #株式総数 |
---|---|---|---|---|---|---|---|
Blaser Brian J. | President and CEO |
Dec 11 '24 |
Buy |
41.42 |
6,033 |
249,878 |
6,033 |
大文字化:
|
ボリューム (24 時間):